financetom
Business
financetom
/
Business
/
India's Tejas jet-maker HAL calls Dubai crash an isolated occurrence
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
India's Tejas jet-maker HAL calls Dubai crash an isolated occurrence
Nov 24, 2025 12:02 AM

Nov 24 (Reuters) - India's Hindustan Aeronautics Ltd

(HAL) said on Monday the crash of a Tejas fighter jet

in Dubai last week was an isolated occurrence caused by

exceptional circumstances, without providing further details.

On Friday, a Tejas fighter jet crashed in a ball of fire in

front of horrified spectators during an aerial display at the

Dubai Airshow. The Indian Air Force has said it will set up a

court of inquiry to investigate the cause.

State-owned Hindustan Aeronautics manufactures the aircraft,

which is powered by General Electric ( GE ) engines. Both

companies have said they will support the investigation.

Tejas, which means brilliance in Sanskrit, is seen as

crucial for India's efforts to modernise its air force fleet of

mainly Russian and ex-Soviet fighters.

The crash, which killed the pilot, dampens New Delhi's hopes

of exporting the home-built jet and leaves it reliant on Indian

military orders to sustain its role as a showcase of domestic

defence technology. Such a public loss could overshadow India's

efforts to establish the jet abroad after a painstaking

development over four decades, experts have said.

Hindustan Aeronautics said on Monday that the crash will not

affect its business operations, financials or future deliveries.

Shares of the company, which were trading 3% lower since

morning, were unchanged after the statement.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
HilleVax Q4 Net Loss Widens; Shares Extend Decline After Hours
HilleVax Q4 Net Loss Widens; Shares Extend Decline After Hours
Mar 20, 2024
05:49 PM EDT, 03/20/2024 (MT Newswires) -- HilleVax ( HLVX ) reported a Q4 net loss late Wednesday of $0.78 per diluted share, compared with a loss of $0.56 a year earlier. Analysts polled by Capital IQ expected a loss of $0.83. As expected, no revenue for the quarter ended Dec. 31 was reported. The clinical-stage biopharmaceutical company said it...
CERAWEEK-Shippers turn to longer-term leases as tanker supply tightens
CERAWEEK-Shippers turn to longer-term leases as tanker supply tightens
Mar 20, 2024
By Arathy Somasekhar and Georgina McCartney HOUSTON, March 20 (Reuters) - Rising oil tanker chartering rates due to global shipping disruption are forcing oil shippers to take on longer-term shipping charters, executives said this week at an energy conference in Houston. The global oil tanker fleet must now travel further to get crude to refineries and fuel to consumers. European...
GitLab Acquires Oxeye to Enhance Application Security Capabilities
GitLab Acquires Oxeye to Enhance Application Security Capabilities
Mar 20, 2024
05:41 PM EDT, 03/20/2024 (MT Newswires) -- GitLab ( GTLB ) said late Wednesday it has acquired Oxeye, which provides cloud-native application security and risk management services, to accelerate its Static Application Security Testing roadmap. The company said its security capabilities will include enhanced SAST scanning technology to reduce false positives and deliver highly accurate results and actionable insights following...
Bristol-Myers Squibb's Multiple Myeloma Treatment Gets European Commission Approval
Bristol-Myers Squibb's Multiple Myeloma Treatment Gets European Commission Approval
Mar 20, 2024
05:44 PM EDT, 03/20/2024 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) said late Wednesday the European Commission approved Abecma to treat adult patients with relapsed and refractory multiple myeloma who have received at least two previous therapies. The approval covers patients who have shown disease progression on the last therapy, the company said. Abecma has maintained its orphan designation...
Copyright 2023-2026 - www.financetom.com All Rights Reserved